AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] Gevo, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 08/05/2025, ACCO Brands (ticker: ACCO) filed a Form 4 disclosing that its SVP, General Counsel & Corporate Secretary, Kathryn D. Ingraham, received an equity award of 28,491 Restricted Stock Units (RSUs) under the company’s Incentive Plan. Each RSU entitles the holder to one share of ACCO common stock on 08/05/2028, contingent upon continued employment, with no exercise price.

No common-stock purchases or sales were reported, and the filing lists 28,491 derivative securities as beneficially owned after the transaction. The grant represents routine executive compensation and does not immediately change the public float; any dilution would occur only upon settlement in 2028.

Il 08/05/2025, ACCO Brands (simbolo: ACCO) ha depositato un Modulo 4 comunicando che la sua SVP, Consigliere Generale e Segretaria Aziendale, Kathryn D. Ingraham, ha ricevuto un premio azionario di 28.491 Unità di Azioni Vincolate (RSU) nell'ambito del Piano Incentivi della società. Ogni RSU dà diritto al titolare a una azione ordinaria ACCO il 08/05/2028, subordinatamente al mantenimento del rapporto di lavoro, senza prezzo di esercizio.

Non sono stati segnalati acquisti o vendite di azioni ordinarie, e il deposito indica 28.491 strumenti finanziari derivati come detenuti in modo beneficiario dopo la transazione. Il premio rappresenta una normale retribuzione esecutiva e non modifica immediatamente il flottante pubblico; qualsiasi diluizione avverrà solo al momento della liquidazione nel 2028.

El 08/05/2025, ACCO Brands (símbolo: ACCO) presentó un Formulario 4 revelando que su SVP, Consejero General y Secretario Corporativo, Kathryn D. Ingraham, recibió una concesión de capital de 28.491 Unidades de Acciones Restringidas (RSU) bajo el Plan de Incentivos de la compañía. Cada RSU otorga al titular una acción ordinaria de ACCO el 08/05/2028, condicionado a la continuidad en el empleo, sin precio de ejercicio.

No se reportaron compras o ventas de acciones ordinarias, y la presentación lista 28.491 valores derivados como propiedad beneficiaria tras la transacción. La concesión representa una compensación ejecutiva habitual y no cambia inmediatamente el flotante público; cualquier dilución ocurrirá solo al momento del pago en 2028.

2025ë…� 8ì›� 5ì�, ACCO Brands(티커: ACCO)ëŠ� SVP ê²� 법률고문 ë°� 기업 비서ì� Kathryn D. Ingrahamì� 회사ì� ì¸ì„¼í‹°ë¸Œ 플랜ì—� ë”°ë¼ 28,491ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 수령했다ê³� Form 4ë¥� 제출했습니다. ê°� RSUëŠ� ê³„ì† ê³ ìš© ì¡°ê±´ í•˜ì— 2028ë…� 8ì›� 5ì�ì—� ACCO 보통ì£� 1주를 ë°›ì„ ê¶Œë¦¬ë¥� 부여하ë©�, 행사 ê°€ê²©ì€ ì—†ìŠµë‹ˆë‹¤.

보통ì£� 매수 ë˜ëŠ” ë§¤ë„ ë‚´ì—­ì€ ë³´ê³ ë˜ì§€ 않았으며, 제출 서류ì—는 거래 í›� 28,491ê°œì˜ íŒŒìƒ ì¦ê¶Œì� 실질 소유ë¡� 기재ë˜ì–´ 있습니다. ì´ë²ˆ 수여ëŠ� ì¼ìƒì ì¸ ìž„ì› ë³´ìƒì—� 해당하며, 즉시 공개 유통 ì£¼ì‹ ìˆ˜ì—ëŠ� ë³€ë™ì´ 없고, í¬ì„ 효과ëŠ� 2028ë…� ì •ì‚° 시ì—ë§� ë°œìƒí•©ë‹ˆë‹�.

Le 08/05/2025, ACCO Brands (symbole : ACCO) a déposé un formulaire 4 révélant que sa SVP, conseillère juridique générale et secrétaire d’entreprise, Kathryn D. Ingraham, a reçu une attribution d’actions de 28 491 unités d’actions restreintes (RSU) dans le cadre du plan d’incitation de la société. Chaque RSU donne droit à une action ordinaire ACCO le 08/05/2028, sous réserve de la poursuite de l’emploi, sans prix d’exercice.

Aucun achat ou vente d’actions ordinaires n’a été signalé, et le dépôt indique 28 491 titres dérivés détenus à titre bénéficiaire après la transaction. Cette attribution constitue une rémunération exécutive habituelle et ne modifie pas immédiatement le flottant public ; toute dilution ne surviendra qu’au moment du règlement en 2028.

Am 08.05.2025 reichte ACCO Brands (Ticker: ACCO) ein Formular 4 ein, das offenlegt, dass seine SVP, General Counsel & Corporate Secretary, Kathryn D. Ingraham, eine Aktienzuteilung von 28.491 Restricted Stock Units (RSUs) im Rahmen des Anreizplans des Unternehmens erhalten hat. Jede RSU berechtigt den Inhaber zum Erhalt einer ACCO-Stammaktie am 08.05.2028, vorbehaltlich einer fortgesetzten Beschäftigung, ohne Ausübungspreis.

Es wurden keine Käufe oder Verkäufe von Stammaktien gemeldet, und die Einreichung listet 28.491 derivative Wertpapiere als wirtschaftlich gehalten nach der Transaktion auf. Die Zuteilung stellt eine routinemäßige Vergütung für Führungskräfte dar und verändert den Streubesitz nicht sofort; eine Verwässerung würde erst bei der Abwicklung im Jahr 2028 eintreten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine RSU grant to ACCO SVP; aligns incentives, minimal near-term dilution, neutral impact on valuation.

The Form 4 records a single Type A transaction: an award of 28,491 RSUs to a senior officer with a three-year cliff vest. Such grants are common for retention and alignment and signal no change in insider sentiment because there were no open-market purchases or sales. At ACCO’s recent price (~$6), the package is worth roughly $0.17 million, immaterial versus the company’s market cap. Dilution potential is <0.04% of outstanding shares and deferred until 2028, so balance-sheet and EPS impact are negligible today. Investors should view the filing as neutral housekeeping rather than a catalyst.

Il 08/05/2025, ACCO Brands (simbolo: ACCO) ha depositato un Modulo 4 comunicando che la sua SVP, Consigliere Generale e Segretaria Aziendale, Kathryn D. Ingraham, ha ricevuto un premio azionario di 28.491 Unità di Azioni Vincolate (RSU) nell'ambito del Piano Incentivi della società. Ogni RSU dà diritto al titolare a una azione ordinaria ACCO il 08/05/2028, subordinatamente al mantenimento del rapporto di lavoro, senza prezzo di esercizio.

Non sono stati segnalati acquisti o vendite di azioni ordinarie, e il deposito indica 28.491 strumenti finanziari derivati come detenuti in modo beneficiario dopo la transazione. Il premio rappresenta una normale retribuzione esecutiva e non modifica immediatamente il flottante pubblico; qualsiasi diluizione avverrà solo al momento della liquidazione nel 2028.

El 08/05/2025, ACCO Brands (símbolo: ACCO) presentó un Formulario 4 revelando que su SVP, Consejero General y Secretario Corporativo, Kathryn D. Ingraham, recibió una concesión de capital de 28.491 Unidades de Acciones Restringidas (RSU) bajo el Plan de Incentivos de la compañía. Cada RSU otorga al titular una acción ordinaria de ACCO el 08/05/2028, condicionado a la continuidad en el empleo, sin precio de ejercicio.

No se reportaron compras o ventas de acciones ordinarias, y la presentación lista 28.491 valores derivados como propiedad beneficiaria tras la transacción. La concesión representa una compensación ejecutiva habitual y no cambia inmediatamente el flotante público; cualquier dilución ocurrirá solo al momento del pago en 2028.

2025ë…� 8ì›� 5ì�, ACCO Brands(티커: ACCO)ëŠ� SVP ê²� 법률고문 ë°� 기업 비서ì� Kathryn D. Ingrahamì� 회사ì� ì¸ì„¼í‹°ë¸Œ 플랜ì—� ë”°ë¼ 28,491ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 수령했다ê³� Form 4ë¥� 제출했습니다. ê°� RSUëŠ� ê³„ì† ê³ ìš© ì¡°ê±´ í•˜ì— 2028ë…� 8ì›� 5ì�ì—� ACCO 보통ì£� 1주를 ë°›ì„ ê¶Œë¦¬ë¥� 부여하ë©�, 행사 ê°€ê²©ì€ ì—†ìŠµë‹ˆë‹¤.

보통ì£� 매수 ë˜ëŠ” ë§¤ë„ ë‚´ì—­ì€ ë³´ê³ ë˜ì§€ 않았으며, 제출 서류ì—는 거래 í›� 28,491ê°œì˜ íŒŒìƒ ì¦ê¶Œì� 실질 소유ë¡� 기재ë˜ì–´ 있습니다. ì´ë²ˆ 수여ëŠ� ì¼ìƒì ì¸ ìž„ì› ë³´ìƒì—� 해당하며, 즉시 공개 유통 ì£¼ì‹ ìˆ˜ì—ëŠ� ë³€ë™ì´ 없고, í¬ì„ 효과ëŠ� 2028ë…� ì •ì‚° 시ì—ë§� ë°œìƒí•©ë‹ˆë‹�.

Le 08/05/2025, ACCO Brands (symbole : ACCO) a déposé un formulaire 4 révélant que sa SVP, conseillère juridique générale et secrétaire d’entreprise, Kathryn D. Ingraham, a reçu une attribution d’actions de 28 491 unités d’actions restreintes (RSU) dans le cadre du plan d’incitation de la société. Chaque RSU donne droit à une action ordinaire ACCO le 08/05/2028, sous réserve de la poursuite de l’emploi, sans prix d’exercice.

Aucun achat ou vente d’actions ordinaires n’a été signalé, et le dépôt indique 28 491 titres dérivés détenus à titre bénéficiaire après la transaction. Cette attribution constitue une rémunération exécutive habituelle et ne modifie pas immédiatement le flottant public ; toute dilution ne surviendra qu’au moment du règlement en 2028.

Am 08.05.2025 reichte ACCO Brands (Ticker: ACCO) ein Formular 4 ein, das offenlegt, dass seine SVP, General Counsel & Corporate Secretary, Kathryn D. Ingraham, eine Aktienzuteilung von 28.491 Restricted Stock Units (RSUs) im Rahmen des Anreizplans des Unternehmens erhalten hat. Jede RSU berechtigt den Inhaber zum Erhalt einer ACCO-Stammaktie am 08.05.2028, vorbehaltlich einer fortgesetzten Beschäftigung, ohne Ausübungspreis.

Es wurden keine Käufe oder Verkäufe von Stammaktien gemeldet, und die Einreichung listet 28.491 derivative Wertpapiere als wirtschaftlich gehalten nach der Transaktion auf. Die Zuteilung stellt eine routinemäßige Vergütung für Führungskräfte dar und verändert den Streubesitz nicht sofort; eine Verwässerung würde erst bei der Abwicklung im Jahr 2028 eintreten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fitzgerald Lindsay Clinton

(Last) (First) (Middle)
C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH
BUILDING C, SUITE 310

(Street)
ENGLEWOOD CO 80112

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Gevo, Inc. [ GEVO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Advocacy & Comms Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/05/2025 S(1) 8,118 D $1.2306(2) 232,199 D
Common Stock 13,329.74 I By 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2024.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ E. Cabell Massey, Attorney-in-Fact 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ACCO Brands file on 08/06/2025?

A Form 4 reporting an insider equity transaction for SVP Kathryn D. Ingraham.

How many RSUs were granted to SVP Kathryn Ingraham?

She received 28,491 Restricted Stock Units.

When will the RSUs awarded to the ACCO insider vest?

They convert to common stock on 08/05/2028, subject to continued employment.

Did the insider sell or purchase any ACCO shares?

No. The filing shows only an RSU grant; no shares were bought or sold.

Does the RSU grant materially dilute existing ACCO shareholders?

Dilution is minimal (<0.04% of shares) and deferred until the RSUs settle in 2028.
Gevo Inc

NASDAQ:GEVO

GEVO Rankings

GEVO Latest News

GEVO Latest SEC Filings

GEVO Stock Data

294.66M
228.50M
4.34%
24.27%
16.82%
Specialty Chemicals
Industrial Organic Chemicals
United States
ENGLEWOOD